Cargando…

Effect of glitazones on the progression of coronary artery disease in type 2 diabetes patients

The effect of thiazolidinediones (TZDs) on the progression of atherosclerosis in diabetes patients remains unclear. There has been heightened interest in recent years in this class of diabetes medications due to the non-glycemic lowering effects, such as altering lipids, inflammation and hematologic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wyatt, Jamison, Nandish, Shailesh, Oliveros, Rene, Zion, Adrienne S, Lujan, Michael S, Chilton, Robert
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2010
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828106/ https://www.ncbi.nlm.nih.gov/pubmed/20191077

Ejemplares similares

Type 2 diabetes drug glitazone may help lowering risk of dementia by 22%
por: Fareed, Areeba, et al.
Publicado: (2023)

Are the adverse effects of glitazones linked to induced testosterone deficiency?
por: Carruthers, M, et al.
Publicado: (2008)

Pleiotropic Effects of Glitazones: A Double Edge Sword?
por: Salomone, Salvatore
Publicado: (2011)

Glitazone use associated with reduced risk of Parkinson's disease
por: Brakedal, Brage, et al.
Publicado: (2017)

Glitazone Treatment and Incidence of Parkinson’s Disease among People with Diabetes: A Retrospective Cohort Study
por: Brauer, Ruth, et al.
Publicado: (2015)

Changes in Glitazone Use Among Office-Based Physicians in the U.S., 2003–2009
por: Cohen, Andrew, et al.
Publicado: (2010)

Cited4 is a sex‐biased mediator of the antidiabetic glitazone response in adipocyte progenitors
por: Bayindir‐Buchhalter, Irem, et al.
Publicado: (2018)

Glitazone Treatment Rescues Phenotypic Deficits in a Fly Model of Gaucher/Parkinson’s Disease
por: Shola-Dare, Oluwanifemi, et al.
Publicado: (2021)

Cardiovascular risk associated with the use of glitazones, metformin and sufonylureas: meta-analysis of published observational studies
por: Pladevall, Manel, et al.
Publicado: (2016)

Comparative analysis of therapeutic efficiency and costs (experience in Bulgaria) of oral antidiabetic therapies based on glitazones and gliptins
por: Filipova, Elena Pavlova, et al.
Publicado: (2015)

The Glitazone Class of Drugs as Carbonic Anhydrase Inhibitors—A Spin-Off Discovery from Fragment Screening
por: Mueller, Sarah L., et al.
Publicado: (2021)

Glitazones and alpha-glucosidase inhibitors as the second-line oral anti-diabetic agents added to metformin reduce cardiovascular risk in Type 2 diabetes patients: a nationwide cohort observational study
por: Chan, Cheng-Wei, et al.
Publicado: (2018)

Novel glitazones as PPARγ agonists: molecular design, synthesis, glucose uptake activity and 3D QSAR studies
por: Mandal, Subhankar P., et al.
Publicado: (2018)

Advances in PPARs Molecular Dynamics and Glitazones as a Repurposing Therapeutic Strategy through Mitochondrial Redox Dynamics against Neurodegeneration
por: Durai, Priya, et al.
Publicado: (2022)

Activation of Peroxisome Proliferator-Activated Receptor-Gamma by Glitazones Reduces the Expression and Release of Monocyte Chemoattractant Protein-1 in Human Mesothelial Cells
por: Sauter, Matthias, et al.
Publicado: (2012)

Takotsubo in Acute and Chronic Coronary Artery Disease
por: Girgis, Mina, et al.
Publicado: (2019)

Design and Development of Novel Glitazones for Activation of PGC-1α Signaling Via PPAR-γ Agonism: A Promising Therapeutic Approach against Parkinson’s Disease
por: Prabhakaran, Prabitha, et al.
Publicado: (2023)

Eicosapentaenoic and Docosahexaenoic Acids Attenuate Progression of Albuminuria in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease
por: Elajami, Tarec K., et al.
Publicado: (2017)

Anti-proliferative activity of oral anti-hyperglycemic agents on human vascular smooth muscle cells: thiazolidinediones (glitazones) have enhanced activity under high glucose conditions
por: Little, Peter J, et al.
Publicado: (2007)

Two Rationally Identified Novel Glitazones Reversed the Behavioral Dysfunctions and Exhibited Neuroprotection Through Ameliorating Brain Cytokines and Oxy-Radicals in ICV-LPS Neuroinflammatory Rat Model
por: Justin, Antony, et al.
Publicado: (2020)

Glycation of Apoprotein A-I Is Associated With Coronary Artery Plaque Progression in Type 2 Diabetic Patients
por: Pu, Li Jin, et al.
Publicado: (2013)

Ideal Cardiovascular Health and the Prevalence and Progression of Coronary Artery Calcification in Adults With and Without Type 1 Diabetes
por: Alman, Amy C., et al.
Publicado: (2014)

Type 1 Diabetes Accelerates Progression of Coronary Artery Calcium Over the Menopausal Transition: The CACTI Study
por: Keshawarz, Amena, et al.
Publicado: (2019)

Prospective Association Between Inflammatory Markers and Progression of Coronary Artery Calcification in Adults With and Without Type 1 Diabetes
por: Alman, Amy C., et al.
Publicado: (2013)

Optimal Choice of Coronary Revascularization and Stent Type in Diabetic Patients with Coronary Artery Disease
por: Harskamp, Ralf E., et al.
Publicado: (2013)

Identification of Susceptibility Variants in ADIPOR1 Gene Associated with Type 2 Diabetes, Coronary Artery Disease and the Comorbidity of Type 2 Diabetes and Coronary Artery Disease
por: Jin, Zening, et al.
Publicado: (2014)

Coronary artery calcium progression after coronary artery bypass grafting surgery
por: Abazid, Rami M, et al.
Publicado: (2021)

Aortic stiffness: pathophysiology, clinical implications, and approach to treatment
por: Sethi, Salil, et al.
Publicado: (2014)

Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria
por: Reinhard, Henrik, et al.
Publicado: (2011)

Metabolomic Signature of Coronary Artery Disease in Type 2 Diabetes Mellitus
por: Stratmann, Bernd, et al.
Publicado: (2017)

Angina due to obstructive coronary artery disease with type 2 diabetes
por: Fox, Kim
Publicado: (2019)

Genetic Predisposition to Coronary Artery Disease in Type 2 Diabetes Mellitus
por: van Zuydam, Natalie R., et al.
Publicado: (2020)

Hemoglobin A(1c) and the Progression of Coronary Artery Calcification Among Adults Without Diabetes
por: Carson, April P., et al.
Publicado: (2015)

Rates and Determinants of Coronary and Abdominal Aortic Artery Calcium Progression in the Veterans Affairs Diabetes Trial (VADT)
por: Saremi, Aramesh, et al.
Publicado: (2010)

Paraoxonase-1 Is Not Associated with Coronary Artery Calcification in Type 2 Diabetes: Results from the PREDICT Study
por: Mackness, Bharti, et al.
Publicado: (2012)

The Role of Epicardial Adipose Tissue in the Development of Atrial Fibrillation, Coronary Artery Disease and Chronic Heart Failure in the Context of Obesity and Type 2 Diabetes Mellitus: A Narrative Review
por: Krishnan, Anirudh, et al.
Publicado: (2022)

Associations of coronary artery calcified plaque density with mortality in type 2 diabetes: the Diabetes Heart Study
por: Raffield, Laura M., et al.
Publicado: (2018)

Frequency of subclavian artery stenosis in patients with mammarian artery coronary bypass and suspected coronary artery disease progression
por: Müller, Arne M., et al.
Publicado: (2022)

Coronary (18)F-Fluoride Uptake and Progression of Coronary Artery Calcification
por: Doris, Mhairi K., et al.
Publicado: (2020)

High-risk coronary artery plaque in asymptomatic patients with type 2 diabetes: clinical risk factors and coronary artery calcium score
por: Heinsen, Laurits Juhl, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uaa91h6tr23sdo9rpklr1kddqk